EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, molecular docking, anti-inflammatory and antioxidant activity of novel 2-(1-(4-(4-chlorophenyl) thiazol-2-yl)-1H-pyrazol-4-yl)benzo[d]oxazoles

Nirmala Darekar iD, Hemantkumar Akolkar iD, Sushama Takate, Dilip Thube iD, Dipak Raut iD, Vijay Khedkar iD, Dnyaneshwar Sirsat, Sadhana Mhaske iD

Acta Chimica Slovenica · 25.09.2026 · 73 (3) · 677-685

DOI: 10.17344/acsi.2026.9704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Chimica Slovenica, online erschienen am 25.09.2026. Verfasst von Nirmala Darekar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Radhabai Kale Mahila Mahavidyalaya, Ahmednagar, Maharashtra, 414001, India. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Antioxidants, Drug Design, Anti-Inflammatory Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of novel 2-(1-(4-(4-chlorophenyl)thiazol-2-yl)-1H-pyrazol-4-yl)benzo[d]oxazoles 5 were synthesized from 2-[(E)-{1-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-1H-pyrazol-4-yl}(hydroxyimino)methyl]phenol 4 through Beckmann rearrangement. All the synthesized compounds were characterized with the help of IR, 1H and 13C NMR and LCMS techniques. All the synthesized compounds were screened for their in vitro anti-inflammatory and antioxidant activities. Among the newly synthesized compounds, compound 5c and 5e showed good anti-inflammatory activity and compounds 5c and 5d showed good antioxidant activity. Molecular docking study could provide valuable insights into the mechanism of anti-inflammatory activity. Furthermore, molecular docking studies into the active site of COX-2 enzyme indicated that compound 5c binds with good affinity, which is consistent with its considerable efficacy in the in vitro tests.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationAntioxidantsDrug DesignAnti-Inflammatory AgentsBenzoxazolesAnimals

Substanzen

AntioxidantsAnti-Inflammatory AgentsBenzoxazoles

Autor:innen und Institutionen

  • Department of Chemistry, Radhabai Kale Mahila Mahavidyalaya, Ahmednagar, Maharashtra, 414001, India.
  • Department of Chemistry, Abasaheb Marathe Arts and New Commerce, Science College, Rajapur, Ratnagiri, Maharashtra, 416702, India.
  • P.G. and Research, Department of Chemistry, New Arts, Science and Commerce College, Ahmednagar, Maharashtra, 414001, India.
  • P.G. and Research, Department of Chemistry, New Arts, Science and Commerce College, Parner, Maharashtra, 414302, India.
  • Department of Pharmacognosy, Amrutvahini College of Pharmacy, Sangamner, Maharashtra, India.
  • School of Pharmacy, Vishwakarma University, Pune, Maharashtra, 411 048, India.

ORCID-Profile: Nirmala Darekar, Hemantkumar Akolkar, Dilip Thube, Dipak Raut, Vijay Khedkar, Sadhana Mhaske

Zitieren

APA

Darekar, N., Akolkar, H., Takate, S., Thube, D., Raut, D., Khedkar, V., Sirsat, D., & Mhaske, S. (2026). Design, synthesis, molecular docking, anti-inflammatory and antioxidant activity of novel 2-(1-(4-(4-chlorophenyl) thiazol-2-yl)-1H-pyrazol-4-yl)benzo[d]oxazoles. Acta Chimica Slovenica, 73(3), 677-685. https://doi.org/10.17344/acsi.2026.9704

Vancouver

Darekar N, Akolkar H, Takate S, Thube D, Raut D, Khedkar V, et al. Design, synthesis, molecular docking, anti-inflammatory and antioxidant activity of novel 2-(1-(4-(4-chlorophenyl) thiazol-2-yl)-1H-pyrazol-4-yl)benzo[d]oxazoles. Acta Chimica Slovenica. 2026;73(3):677-685. doi:10.17344/acsi.2026.9704

BibTeX
@article{Darekar2026,
  author = {Darekar, Nirmala and Akolkar, Hemantkumar and Takate, Sushama and Thube, Dilip and Raut, Dipak and Khedkar, Vijay and Sirsat, Dnyaneshwar and Mhaske, Sadhana},
  title = {Design, synthesis, molecular docking, anti-inflammatory and antioxidant activity of novel 2-(1-(4-(4-chlorophenyl) thiazol-2-yl)-1H-pyrazol-4-yl)benzo[d]oxazoles},
  journal = {Acta Chimica Slovenica},
  year = {2026},
  volume = {73},
  number = {3},
  pages = {677--685},
  doi = {10.17344/acsi.2026.9704}
}
Kostenlos starten →